Epigenetic Biomarkers in Progression From Non-Dysplastic Barrett's Oesophagus to Oesophageal Adenocarcinoma: A Systematic Review Protocol

BMJ Open - United Kingdom
doi 10.1136/bmjopen-2016-013361
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

BMJ

Related search

GATA6 Expression in Barrett's Oesophagus and Oesophageal Adenocarcinoma

Digestive and Liver Disease
HepatologyGastroenterology
2015English

Repurposing of KLF5 Activates a Cell Cycle Signature During the Progression From Barrett's Oesophagus to Oesophageal Adenocarcinoma.

2020English

New Models of Neoplastic Progression in Barrett's Oesophagus

Biochemical Society Transactions
Biochemistry
2010English

Research Priority Setting in Barrett's Oesophagus and Gastro-Oesophageal Reflux Disease

Lancet Gastroenterology and Hepatology, The
HepatologyGastroenterology
2017English

Acid Suppression Medications Reduce Risk of Oesophageal Adenocarcinoma in Barrett's Oesophagus: A Nested Case-Control Study in US Male Veterans

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Barrett's Oesophagus.

Postgraduate Medical Journal
Medicine
1998English

Photodynamic Therapy for Dysplastic Barrett's Oesophagus: A Prospective, Double Blind, Randomised, Placebo Controlled Trial

Gut
Gastroenterology
2000English

PTU-159 Characterisation of Oesophageal Muc1 Expression in the Progression to Oesophageal Adenocarcinoma

Gut
Gastroenterology
2013English

Dietary Fat Intake in the Aetiology of Barrett's Oesophagus and Oesophageal Adenocarcinoma: Data From a Prospective Cohort Study (EPIC-Norfolk) Using 7-Day Food Diary Data

Gut
Gastroenterology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy